Amjad Waseem, Haider Rabbia, Malik Adnan, Qureshi Waqas
Internal Medicine, Albany Medical Center, Albany, NY, USA.
Internal Medicine, Nishter Medical University, Multan, Punjab, Pakistan.
Therap Adv Gastroenterol. 2021 Jul 9;14:17562848211028117. doi: 10.1177/17562848211028117. eCollection 2021.
Coronavirus 2019 disease (COVID-19) has created major impacts on public health. The virus has plagued a large population requiring hospitalization and resource utilization. Knowledge about the COVID-19 virus continues to grow. It can commonly present with gastrointestinal symptoms; initially, this was considered an atypical presentation, which led to delays in care. The pandemic has posed serious threats to the care of anorectal diseases. Urgent surgeries have been delayed, and the care of cancer patients and cancer screenings disrupted. This had added to patient discomfort and the adverse outcomes on healthcare will continue into the future. The better availability of personal protective equipment to providers and standard checklist protocols in operating rooms can help minimize healthcare-related spread of the virus. Telehealth, outpatient procedures, and biochemical tumor marker tests can help with mitigation of anorectal-disease-related problems. There is limited literature about the clinical management of anorectal diseases during the pandemic. We performed a detailed literature review to guide clinicians around management options for anorectal disease patients. We also highlighted the health challenges seen during the pandemic.
2019冠状病毒病(COVID-19)对公共卫生造成了重大影响。该病毒困扰了大量需要住院治疗和资源利用的人群。关于COVID-19病毒的知识不断增加。它通常会出现胃肠道症状;最初,这被认为是非典型表现,导致治疗延误。这场大流行对肛肠疾病的治疗构成了严重威胁。紧急手术被推迟,癌症患者的治疗和癌症筛查也受到干扰。这增加了患者的不适,而且对医疗保健的不良影响将持续到未来。为医护人员提供更多的个人防护设备以及手术室中的标准检查清单协议有助于最大限度地减少与医疗保健相关的病毒传播。远程医疗、门诊手术和生化肿瘤标志物检测有助于缓解与肛肠疾病相关的问题。关于大流行期间肛肠疾病临床管理的文献有限。我们进行了详细的文献综述,以指导临床医生对肛肠疾病患者的管理选择。我们还强调了大流行期间出现的健康挑战。